Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia R Murray

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JAMA Oncology|March 14, 2024
Hypofractionation for Postprostatectomy RadiotherapyJulia R Murray
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 20, 2018
Imaging and radiotherapy for recurrent prostate cancer: An evolutionary partnershipJulia R Murray, Klaus Kopka, Ali Afshar-Oromieh
Cancer Management and Research|December 5, 2015
Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Julia R Murray, Helen A McNair, David P Dearnaley
Clinical Endocrinology|December 17, 2011
Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm?Julia R Murray, Graham R Williams, Kevin J Harrington, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2019
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE TrialJulia R Murray, Alison C Tree, Emma J Alexander, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JAMA Oncology|March 14, 2024
Hypofractionation for Postprostatectomy RadiotherapyJulia R Murray
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 20, 2018
Imaging and radiotherapy for recurrent prostate cancer: An evolutionary partnershipJulia R Murray, Klaus Kopka, Ali Afshar-Oromieh
Cancer Management and Research|December 5, 2015
Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Julia R Murray, Helen A McNair, David P Dearnaley
Clinical Endocrinology|December 17, 2011
Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm?Julia R Murray, Graham R Williams, Kevin J Harrington, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2019
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE TrialJulia R Murray, Alison C Tree, Emma J Alexander, et al.
Pageof 1